Israel Englander Pliant Therapeutics, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 244,640 shares of PLRX stock, worth $3.25 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

244,640

Previous 73,290 233.8%

Holding current value

$3.25 Million

Previous $787,000 248.41%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$10.52 - $14.35 $1.8 Million - $2.46 Million	171,350 Added 233.8%	244,640 $2.74 Million
Q2 2024 Aug 14, 2024	BUY	$10.58 - $15.61 $452,305 - $667,343	42,751 Added 139.99%	73,290 $787,000
Q1 2024 May 15, 2024	BUY	$14.14 - $19.59 $431,821 - $598,259	30,539 New	30,539 $455,000
Q2 2023 Aug 14, 2023	SELL	$18.12 - $30.56 $258,028 - $435,174	-14,240 Reduced 3.83%	357,563 $6.48 Million
Q1 2023 May 15, 2023	BUY	$18.73 - $36.26 $3.09 Million - $5.99 Million	165,072 Added 79.85%	371,803 $9.89 Million
Q4 2022 Feb 14, 2023	BUY	$17.0 - $25.43 $218,433 - $326,750	12,849 Added 6.63%	206,731 $4 Million
Q3 2022 Nov 14, 2022	SELL	$7.67 - $24.23 $201,958 - $638,000	-26,331 Reduced 11.96%	193,882 $4.05 Million
Q2 2022 Aug 15, 2022	BUY	$4.11 - $8.75 $666,420 - $1.42 Million	162,146 Added 279.24%	220,213 $1.76 Million
Q1 2022 May 16, 2022	SELL	$7.01 - $14.1 $43,433 - $87,363	-6,196 Reduced 9.64%	58,067 $407,000
Q4 2021 Feb 14, 2022	BUY	$12.27 - $18.26 $378,738 - $563,631	30,867 Added 92.43%	64,263 $868,000
Q3 2021 Nov 15, 2021	BUY	$16.48 - $28.98 $264,948 - $465,911	16,077 Added 92.83%	33,396 $564,000
Q2 2021 Aug 16, 2021	SELL	$28.05 - $37.69 $1.29 Million - $1.74 Million	-46,047 Reduced 72.67%	17,319 $504,000
Q1 2021 May 17, 2021	BUY	$24.52 - $40.23 $774,096 - $1.27 Million	31,570 Added 99.29%	63,366 $2.49 Million
Q4 2020 Feb 16, 2021	BUY	$19.89 - $32.99 $291,348 - $483,237	14,648 Added 85.42%	31,796 $722,000
Q3 2020 Nov 16, 2020	SELL	$21.54 - $29.53 $1.14 Million - $1.56 Million	-52,920 Reduced 75.53%	17,148 $388,000
Q2 2020 Aug 14, 2020	BUY	$21.3 - $35.26 $1.49 Million - $2.47 Million	70,068 New	70,068 $2.27 Million

Others Institutions Holding PLRX

# of Institutions

168

Shares Held

63.2M

Call Options Held

245K

Put Options Held

373K

View Full List

About PLIANT THERAPEUTICS, INC.

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $647M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

More about PLRX

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account